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Introduction:  Progeroid syndromes are characterized by accelerated aging and early development of dis-
eases typically associated with aging. Premature development of tumors including BPH, maybe observed
in these patients, which can lead to significant bladder outlet obstruction.
Observation:  The index patient was a 23 year old man who presented to us with lower urinary tract symptoms
(LUTS), features of obstructive nephropathy and was noticed to have been aging rapidly. He had features
of premature aging, bilateral cataract and enlarged benign prostate (BPH). He eventually succumbed to
obstructive nephropathy and urosepsis.
Conclusion:  Progeroid syndromes may be associated with premature development of obstructive BPH.
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remature aging diseases are well documented in the literature, how-
ver their exact aetiology remains to be fully unraveled. They have
lso stimulated interest in the search for the exact mechanism/s of
ormal aging process; consequently this has lead to better under-
tanding of aging. To date more than 75 syndromes with features
f premature aging are recognized and collectively referred to as
rogeroid  Syndromes, by analogy with progeria [1]. Progeria also
alled “Hutchinson Gilford Syndrome”, is a clinical aging syndrome
hat was first described in 1886, it becomes evident in early child-
ood and progresses rapidly, ending in death at an early age (13–17)
2]. However, over the cause of time many early aging syndromes
nd hosting by Elsevier B.V. This is an open access article under the CC
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ataract in one of the eyes.
ere described with varied presentations and manifestations giving
ise to the term “Progeroid syndromes”. The premature aging syn-
romes described in literature to date include; Hutchinson Gilford
yndrome, Werner syndrome, Ataxia telangiectasia, Xeroderma pig-
entosum, Cockayne syndrome, Fanconi syndrome & Bloom and
othmund Thomson syndrome [1].
here are disease conditions typically associated with normal aging,
ne of the common diseases is benign prostatic hyperplasia (BPH);
t is characterized by stromal and epithelial proliferation of the tran-
ition zone of the prostate [3]. BPH is typically begins from middle
ge, it has not been demonstrated histologically in men younger
han 30 years and most clinical BPH are seen beyond forty years [3].
PH is thought to be initiated by senescent epithelial cells located
n the prostate. These cells secrete the cytokines IL-1 and IL-8
hat stimulate stromal growth factor secretion, which in turn corre-
ates with proliferation of the non-senescent epithelial cells [4–6].
rogeroid syndromes are characterized by premature senescence,
hich affects many organs including the prostate [2,7], thus the
otential development of BPH in patients with accelerated aging
isorders.
ase  summary
e reviewed the case records of a 23 year old man after obtaining
ritten informed consent from the next of kin and ethical clearance
rom our hospital’s health research ethics committee (HREC). He
resented to our outpatient clinic from a peasant rural community
ith progressive obstructive and irritative lower urinary tract symp-
oms (LUTS) of over a year. He subsequently developed malaise,
norexia and bilateral lower limbs swelling. There was no history
f trauma to the pelvis or perineum and no history of haematuria.
e was noticed to be aging faster than usual, with progressively





xamination revealed an elderly looking man (Fig. 1(a)) with bald-
ng, and thin sparse hair with marked greying, he had wrinkled
trophic skin, bilateral cataract (Fig. 1(b)), multiple missing teeth
nd bilateral pitting pedal oedema. He had a painless distended blad-
er up to the umbilicus and the prostate was moderately enlarged
ith benign features.
 diagnosis of obstructive nephropathy secondary to BPH in a
atient with progeroid syndrome was made. Ultrasound confirmed
he enlarged prostate (42 g) with a postvoid residual urine of about
000 ml. Serum urea, electrolyte and creatinine were markedly
eranged. The patient was catheterized and maintained on con-
inuous bladder drainage. However, on follow up visit, there was
o significant improvement of renal function despite continuous
ladder drainage, he subsequently developed urosepsis and pro-
ressively deteriorated until he ultimately succumbed a month after
iagnosis.
iscussion
rogeroid syndromes have variable manifestations but they all have
ccelerated aging as a common denominator. Progeroid syndromes
ay either be Unimodal or Segmental; unimodal progeroid syn-
romes affects only a single organ unlike the segmental progeroid
yndromes that manifest in several organs. The common char-
cteristics of segmental progeroid syndromes is the concurrent
nset of premature aging in several organs, which may involve
he skin and the skeletal system with osteoporosis and degen-
rative diseases features, early onset arthritis, vascular diseases,
iabetes mellitus, marked atrophy of subcutaneous fat. Other mani-
estations include; neurodegenerative diseases, increased incidence
f various tumors, increased incidence of autoimmune diseases,
mpaired immune function and increased predisposition to infec-
ion [1,8]. The index patient had multiple organ involvement
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erated aging, early balding and greying, atrophic degenerative
skin (wrinkled skin), dental loss, bilateral cataract (Fig. 1(a)) and
prostatic enlargement consistent with segmental progeroid syn-
dromes.
In order to ensure uniformity of description of these syndromes
with diverse manifestations, criteria for diagnosis were developed.
The criteria are divided into clinical and genetic criteria [1,2].
The clinical criteria include; one or more tumours, which are
typical in older age group (BPH in our patient), premature devel-
opment of grey hair, hair loss, impaired memory; other criteria are;
increased susceptibility to slow virus disease, pigment disorders or
regional fibrosis in the skin, altered distribution of adipose tissues,
hypogonadism, degenerative vascular disease/hypertension, osteo-
porosis, arthritis/other degenerative bone diseases and cataracts. The
genetic criteria include; genomic instability and non-constitutional
chromosomal aberrations, defects in stem cell population or in
the proliferation of stem cells and mitochondrial changes in one
or more tissues [1,9]. Our patient had most of these clinical
criteria, however we could not establish the genetic compo-
nent.
Cellular senescence (aging) is an established key factor in the patho-
genesis of the manifestations of progeroid syndromes [7]. The role
of telomeres in cellular senescence and apoptosis has been an area of
extensive investigation. Research has demonstrated that irreversible
growth arrest (cell senescence) is to a large extent a consequence of
short telomeres, which activate DNA damage response pathways.
Many progeroid syndromes in mice and humans were shown to
originate from mutations that disrupt DNA repair and/or DNA dam-
age responses, resulting in an increased incidence of tumours that
usually occur at a decreased latency. Several evidences have been
presented to confirm that premature and rapid cellular senescence
is linked with increased rates of telomere shortening [8–10].
Benign prostatic hyperplasia is a disease associated with aging, it is
a manifestation of progressive proliferation of the transition zone of
the prostate [3,5,6]. It has been shown by several studies on aging
process that, this proliferation is probably due to the presence of
senescent epithelial cells in the prostate. The mechanistic process
of cellular proliferation is believed to be induced by cytokines (IL-
1  and IL-8) secreted by the senescent cells, which stimulate the
production stromal growth factors and consequently induction of
proliferation of non senescent epithelial cells [4,6,11,12]. The over-
all effect of the activation of the senescence pathways in the prostate
is progressive enlargement of the transition zone (BPH), which
manifested in the index patient. This patient progressed to develop
bladder outlet obstruction and eventually obstructive nephropathy,
which contributed in part to the deterioration in health of the patient
and eventual death.
Conclusion
The hallmark of progeroid syndromes is accelerated aging and the
early development of diseases typically associated with aging. Pre-
mature (23 years in the index patient) development of BPH maybe
observed in these patients and can lead to significant bladder outlet
obstruction and obstructive nephropathy. This report provides addi-
tional evidence for the pivotal role of senescence pathways in the
pathogenesis of progeroid syndromes and BPH.
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